Filana Therapeutics, Inc. Property, Plant and Equipment, Gross
Filana Therapeutics, Inc. (FLNA) had Property, Plant and Equipment, Gross of $24.77 million as of 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-05-07
- 2026-03-31: Property, Plant and Equipment, Gross $24.77M.
- 2025-12-31: Property, Plant and Equipment, Gross $24.79M.
- 2025-09-30: Property, Plant and Equipment, Gross $24.73M.
- 2025-06-30: Property, Plant and Equipment, Gross $24.23M.
| Period end | Property, Plant and Equipment, Gross | Property, Plant and Equipment, Gross as first filed |
|---|---|---|
| 2026-03-31 | $24.77M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $24.79M 10-Q · filed 2026-05-07 | |
| 2025-09-30 | $24.73M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $24.23M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $24.23M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $24.24M 10-K · filed 2026-03-12 | $24.20M 10-K · filed 2025-03-03 |
| 2024-09-30 | $24.14M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $24.14M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $24.14M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $24.14M 10-K · filed 2025-03-03 | |
| 2023-09-30 | $24.09M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $24.07M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $24.08M 10-Q · filed 2023-05-01 | |
| 2022-12-31 | $24.06M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $24.06M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $22.90M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $21.44M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $21.01M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $20.91M 10-Q · filed 2021-11-15 | |
| 2020-12-31 | $97.00K 10-K · filed 2022-03-01 | |
| 2020-09-30 | $892.00K 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $892.00K 10-Q · filed 2021-08-04 | |
| 2012-12-31 | $629.00K 10-K · filed 2013-02-08 | |
| 2011-12-31 | $1.33M 10-K · filed 2013-02-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |